+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Macular Degeneration"

From
From
From
From
From
From
From
From
From
Sunglasses - Global Strategic Business Report - Product Thumbnail Image

Sunglasses - Global Strategic Business Report

  • Report
  • March 2025
  • 89 Pages
  • Global
From
Eyewear Market Report 2025 - Product Thumbnail Image

Eyewear Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Eye Health Supplements - Global Strategic Business Report - Product Thumbnail Image

Eye Health Supplements - Global Strategic Business Report

  • Report
  • March 2025
  • 246 Pages
  • Global
From
Spectacle Lens Market Report, Global, 2024 - Product Thumbnail Image

Spectacle Lens Market Report, Global, 2024

  • Report
  • July 2024
  • 175 Pages
  • Global
From
Macular Degeneration Treatment Market Report 2025 - Product Thumbnail Image

Macular Degeneration Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Eye Health Supplements Market Report 2025 - Product Thumbnail Image

Eye Health Supplements Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Retinal Biologics Market Report 2025 - Product Thumbnail Image

Retinal Biologics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Loading Indicator

Macular Degeneration is a condition that affects the central part of the retina, known as the macula, which is responsible for sharp, central vision. It is the leading cause of vision loss in people over the age of 50. Optical treatments for Macular Degeneration include laser photocoagulation, photodynamic therapy, and anti-VEGF injections. Laser photocoagulation is used to reduce the risk of further vision loss by sealing off leaking blood vessels in the macula. Photodynamic therapy is used to reduce the growth of abnormal blood vessels in the macula. Anti-VEGF injections are used to reduce the growth of abnormal blood vessels and improve vision. Companies in the Macular Degeneration market include Novartis, Regeneron, Allergan, Genentech, and Roche. Show Less Read more